dr. locke discusses long-term follow-up of zuma-1 trial for nhl
Published 6 years ago • 65 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
1:08
dr. locke on the zuma-6 trial of axi-cel with atezolizumab for dlbcl
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
2:00
zuma-1 trial: fda approval and follow-up of car t-cell product axicabtagene ciloleucel
-
0:58
advin laparoscopic bipolar l hook electrode
-
6:21
sattva s. neelapu, md: encouraging results for car t-cells in refractory dlbcl
-
8:18
🔶 clarius review 🔶 l pocus hand-held ultrasound for cardiac echo!
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
1:01
frederick locke, md, explains the zuma-1 results and what it means to dlbcl patients
-
1:41
zuma-1: 3-year follow-up on axi-cel in lbcl patients
-
6:45
anticipation of zuma-7 results
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
1:15
primary overall survival analysis of the zuma-7 trial
-
3:49
frederick locke on axi-cel and zuma-7
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use
-
2:43
frederick locke | asco 18 | axi-cel dor in r/r large b-cell lymphoma patients in zuma-1
-
4:26
axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large b-cell lymphoma
-
6:40
frederick locke: axi-cel vs. standard of care in aggressive lbcl
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
1:09
dr. neelapu discusses efficacy of axi-cel in large b-cell lymphoma
-
9:21
fda approval for axi-cel in nhl